By InvestAdvocate

Lagos (INVESTADVOCATE)-Drugmaker, GlaxoSmithKline Consumer Nigeria Plc said on Wednesday its third quarter (Q3) Profit after tax (PAT) for the period ended September 30, 2015 declined 67.21 percent to N485.94 million from N1.48 billion recorded a year ago.

Similarly, profit before tax (PBT) dropped 66 percent to N700.95 million from N2.06 billion posted the review period of 2015.

However, revenue of GlaxoSmithKline decreased marginally from N23.211 billion to N23.040 billion; showing a slight depreciation of 0.74 percent, the drugmake said in a filing with the Nigerian Stock Exchange (NSE).